A combination of physician groups, including the American Heart Association, American Dental Association, American College of Cardiology, American College of Surgeons, Society of Cardiovascular Angiography and Interventions, has issued a new advisory that heart patients with drug-coated stents should stay on anti-clotting drugs for at least one year. Stents are used to prop open arteries. Drug-coated stents release medication that help prevent reclogging of the arteries, but they carry an increased risk of blood clotting. In light of the new information about drug-coated stents, before the stent surgery, doctors should talk to patients about the recommended post-surgery drug therapy. A bare metal stent, rather than a drug-coated stent, may be preferable if a patient will not be able to continue the anti-clotting drugs for at least one year.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.